BACKGROUND & OBJECTIVES Most studies on the clinical presentation with influenza viruses have been conducted in outpatient or inpatient medical facilities with only a few studies in community settings. Clinical differences between influenza A (H1N1) pdm 09 and influenza B virus infections have importance for community-based public health surveillance. An active community surveillance at the tim...

OBJECTIVE To estimate influenza-associated mortality in urban China. METHODS Influenza-associated excess mortality for the period 2003-2008 was estimated in three cities in temperate northern China and five cities in the subtropical south of the country. The estimates were derived from models based on negative binomial regressions, vital statistics and the results of weekly influenza virus su...

BACKGROUND Both pandemic and interpandemic influenza is associated with high morbidity and mortality worldwide. Seasonal epidemics are caused by both influenza A and B virus strains that cocirculate with varying predominance and may give rise to severe illness equally. According to World Health Organization recommendations, current annual vaccines are composed of 2 type A and 1 type B virus-spe...

BACKGROUND & OBJECTIVES During the post influenza pandemic period, continuous surveillance of influenza virus and its subtypes is mandatory to help the policy makers to take effective and appropriate decisions. Therefore, this study was planned to determine the pattern of influenza virus activity in context to various meteorological and clinical parameters in and around Lucknow, Uttar Pradesh, ...

Antibody prevalence against respiratory viruses was noted, as follows: adenovirus (1.3%), influenza A (0.6%), influenza B (12.7%), parainfluenza-1 (22.3%), parainfluenza-2 (2.5%), parainfluenza-3 (18.5%) and respiratory syncytial virus (0.6%). The difference in antibody prevalence between the different virus antigens was statistically significant. High antibody rates to influenza B, parainfluen...

The effectiveness of the 2012/13 trivalent seasonal influenza vaccine (TIV) was assessed using a test-negative case-control study of patients consulting primary care with influenza-like illness in the United Kingdom. Strain characterisation was undertaken on selected isolates. Vaccine effectiveness (VE) against confirmed influenza A(H3N2), A(H1N1) and B virus infection, adjusted for age, sex, s...

Aim: Chronic kidney disease creates a tendency to infections, and infections are the second most common reason for mortality following cardiovascular events in chronic disease. Health authorities recommend vaccination against hepatitis B, annual influenza, pneumonia, zoster, tetanus, new coronavirus people with end-stage Vaccine-preventable diseases cause adult population diseases.
 The pr...

Influenza activity varied across Europe during the 2002-2003 season both in terms of the intensity of clinical activity and the circulating virus types/subtypes. Influenza B was generally predominant in the 'western' parts of Europe (Portugal, Spain, the United Kingdom and Ireland) and influenza A (H3N2) in the 'central' and 'eastern' areas (Germany, Italy, Denmark, Switzerland, Poland, Sloveni...

avian influenza is one of the most important diseases in avian industry, which also threats human population. thus, vaccination is necessary for controlling this viral disease. in this study, killed vaccine of avian influenza subtype h9n2 and formalin solution (for virus inactivation) were used. it is necessary to study the effect of different factors such as formalin concentration, as well as ...

Background and Aims: Influenza is an acute respiratory illness that is caused by a virus belonging to Orthomyxoviridae family. This virus spreads rapidly every year in cold season and leads to morbidities and mortalities especially in adults and children, which causes billions of dollars of economic losses. Accordingly, development of a rapid, sensitive and inexpensive laboratory diagnosis base...